Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-4065PMID 16585209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serological identification of adult T‐cell leukaemia‐associated antigens

  2005cited by this paper
• The spliceosome: a novel multi-faceted target for therapy.

  2005cited by this paper
• Treatment for pancreatic cancer: current therapy and continued progress.

  2005cited by this paper
• Surgery for pancreatic cancer: recent controversies and current practice.

  2005cited by this paper
• Recent updates on the role of chemotherapy in pancreatic cancer.

  2005cited by this paper
• Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9.

  2004cited by this paper
• Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis.

  2004cited by this paper
• Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.

  2004cited by this paper
• Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria‐mediated apoptosis

  2004cited by this paper
• Expression of splicing factors in human ovarian cancer.

  2004cited by this paper
• Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: Implications for pre‐mRNA processing

  2004cited by this paper
• Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA.

  2004cited by this paper
• An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.

  2003cited by this paper
• The spliceosome: the most complex macromolecular machine in the cell?

  2003cited by this paper
• Phosphorylation-dependent and -independent Nuclear Import of RS Domain-containing Splicing Factors and Regulators*

  2003cited by this paper
• A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.

  2002cited by this paper
• Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.

  2002cited by this paper
• Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma.

  2002cited by this paper
• Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents

  2002cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line.

  2001cited by this paper
• Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells

  2001cited by this paper
• Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.

  2001cited by this paper
• Human MUC4 mucin cDNA and its variants in pancreatic carcinoma.

  2000cited by this paper
• Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.

  2000cited by this paper
• Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.

  2000cited by this paper
• Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.

  2000cited by this paper
• Progression model for pancreatic cancer.

  2000cited by this paper
• SR protein-specific kinase 1 is highly expressed in testis and phosphorylates protamine 1.

  1999cited by this paper
• Localization of serine kinases, SRPK1 (SFRSK1) and SRPK2 (SFRSK2), specific for the SR family of splicing factors in mouse and human chromosomes.

  1999cited by this paper
• Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis

  1999cited by this paper
• Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles.

  1998cited by this paper
• SRPK2: A Differentially Expressed SR Protein-specific Kinase Involved in Mediating the Interaction and Localization of Pre-mRNA Splicing Factors in Mammalian Cells

  1998cited by this paper
• Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.

  1997cited by this paper
• SRPK1 and Clk/Sty Protein Kinases Show Distinct Substrate Specificities for Serine/Arginine-rich Splicing Factors*

  1996cited by this paper
• SR proteins and splicing control.

  1996cited by this paper
• Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16.

  1996cited by this paper
• SR proteins: a conserved family of pre-mRNA splicing factors.

  1992cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper

• HPV-driven transcriptome and splicing rewiring under SRPK1 inhibition in cervical cancer

  2026cites this paper
• Serine/Arginine Protein Kinase Inhibitors Potentiate Melanoma Cell Death and Metastatic Inhibition Through Apoptotic Protein Triggering and Vimentin Dysregulation

  2025cites this paper
• Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells

  2025cites this paper
• Epitranscriptomic sculpting: the role of m6A in alternative splicing, cancer progression, and methodological insights

  2025cites this paper
• Exploring the Structural Dynamics of SRPK1 to Identify Competitive Inhibitors via Molecular Modeling Techniques.

  2025cites this paper
• Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets

  2024cites this paper
• LTR Retrotransposon-Derived LncRNA LINC01446 Promotes Hepatocellular Carcinoma Progression and Angiogenesis by Regulating the SRPK2/SRSF1/VEGF Axis.

  2024cites this paper
• SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells.

  2024cites this paper
• Screening Splice-Switching Antisense Oligonucleotides in Pancreas-Cancer Organoids

  2024cites this paper
• Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders

  2023cites this paper
• Preclinical Screening of Splice-Switching Antisense Oligonucleotides in PDAC Organoids

  2023cites this paper
• Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities

  2023cites this paper
• Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential

  2023cites this paper
• First evidence of a serine arginine protein kinase (SRPK) in leishmania braziliensis and its potential as therapeutic target.

  2022cites this paper
• Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression

  2022cites this paper
• Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis

  2022influential citation
• Good Cop, Bad Cop: The Different Roles of SRPKs

  2022cites this paper
• SR Protein Kinases Regulate the Splicing of Cardiomyopathy-Relevant Genes via Phosphorylation of the RSRSP Stretch in RBM20

  2022cites this paper
• MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1

  2022cites this paper
• Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells

  2022cites this paper
• Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells

  2021cites this paper
• RBM10 regulates human TERT gene splicing and inhibits pancreatic cancer progression.

  2021cites this paper
• PRMT5: An Emerging Target for Pancreatic Adenocarcinoma

  2021cites this paper
• Oncogenic dysregulation of pre‐mRNA processing by protein kinases: challenges and therapeutic opportunities

  2021cites this paper
• Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies

  2021cites this paper
• SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

  2020cites this paper
• Roles of Splicing Factors in Hormone-Related Cancer Progression

  2020cites this paper
• Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies

  2020cites this paper
• Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma

  2020cites this paper
• Phosphoproteomics Reveals Novel Targets and Phosphoprotein Networks in Cell Cycle Mediated by Dsk1 Kinase.

  2020cites this paper
• RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target

  2020cites this paper
• Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease

  2020cites this paper
• SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

  2020cites this paper
• Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine

  2020cites this paper
• Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives

  2019influential citation
• Insights into the full-length SRPK2 structure and its hydrodynamic behavior.

  2019cites this paper
• Splicing and cancer: Challenges and opportunities

  2019cites this paper
• Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention

  2018cites this paper
• Antimetastatic effect of the pharmacological inhibition of serine/arginine‐rich protein kinases (SRPK) in murine melanoma

  2018cites this paper
• Alternative Splicing (AS) and Epithelial-to-Mesenchymal Transition (EMT) programming in cellular model of breast cancer

  2018influential citation
• Serine/arginine protein kinase (SRPK) inhibition as a potential therapeutic strategy against leukemia cells

  2018cites this paper
• Caspase‐mediated cleavage of X‐ray repair cross‐complementing group 4 promotes apoptosis by enhancing nuclear translocation of caspase‐activated DNase

  2018cites this paper
• Pharmacology of Modulators of Alternative Splicing

  2017cites this paper
• Trifluoromethyl arylamides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs).

  2017cites this paper
• SRPK1‑siRNA suppresses K562 cell growth and induces apoptosis via the PARP‑caspase3 pathway.

  2017cites this paper
• Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options.

  2017cites this paper
• Identification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis

  2016cites this paper
• Splicing-factor alterations in cancers

  2016cites this paper
• Expression of SRPK1 in gliomas and its role in glioma cell lines viability

  2016influential citation
• Serine‐arginine protein kinase 1 promotes a cancer stem cell‐like phenotype through activation of Wnt/β‐catenin signalling in NSCLC

  2016cites this paper
• Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.

  2016cites this paper
• Semi-Penalized Inference with False Discovery Rate Control in High-dimensional Linear Regression

  2016cites this paper
• The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia

  2015cites this paper
• Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance

  2015cites this paper
• Serine-arginine protein kinase 1 is associated with hepatocellular carcinoma progression and poor patient survival

  2015cites this paper
• Vitamin D Receptor and RXR in the Post‐Genomic Era

  2015cites this paper
• Splicing Regulators and Their Roles in Cancer Biology and Therapy

  2015cites this paper
• Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing

  2015cites this paper
• Interactions of cisplatin with non-DNA targets and their influence on anticancer activity and drug toxicity: the complex world of the platinum complex.

  2015cites this paper
• Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS

  2015cites this paper
• Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)

  2015cites this paper
• The PTB-Associated Splicing Factor/Peroxisome Proliferator-Activated Receptor Gamma Axis Regulates Autophagosome Formation in Human Pancreatic Cancer Cells

  2015cites this paper
• Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells.

  2015cites this paper
• Serine–arginine protein kinase 1 is associated with breast cancer progression and poor patient survival

  2014cites this paper
• Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events

  2014cites this paper
• Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.

  2014influential citation
• Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma

  2014cites this paper
• Vitamin D and the RNA transcriptome: more than mRNA regulation

  2014cites this paper
• Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer.

  2013cites this paper
• Molecular mechanisms involved in the acquisition of drug resistance in pancreatic cancer cells

  2013cites this paper
• Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway

  2013cites this paper
• Semi-Penalized Inference with Direct False Discovery Rate Control in High-Dimensions

  2013cites this paper
• SRPK1 contributes to malignancy of hepatocellular carcinoma through a possible mechanism involving PI3K/Akt

  2013cites this paper
• De Novo Design of Protein Kinase Inhibitors by in Silico Identification of Hinge Region-Binding Fragments

  2013cites this paper
• cells by controlling CD56 expression Novel RUNX1 isoforms determine the fate of acute myeloid leukemia

  2013cites this paper
• Clinical perspective on chemo-resistance and the role of RNA processing.

  2013cites this paper
• Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.

  2013cites this paper
• Regulation of splicing by SR proteins and SR protein-specific kinases

  2013cites this paper
• Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer

  2013cites this paper
• Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma

  2012cites this paper
• Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro

  2012influential citation
• The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus.

  2012cites this paper
• Regulation of chemoresistance via alternative messenger RNA splicing.

  2012cites this paper
• Distribution of SRPK1 in human brain.

  2012cites this paper
• Caracterización funcional de SKY1 y su papel en la resistencia de las levaduras a cisplatino

  2012cites this paper
• Global tumor protein p53/p63 interactome

  2012cites this paper
• Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin

  2011cites this paper
• Quantitative chemical proteomics in small‐scale culture of phorbol ester stimulated basal breast cancer cells

  2011influential citation
• Serine‐arginine protein kinases: a small protein kinase family with a large cellular presence

  2011cites this paper
• Improving breast cancer outcome prediction by combining multiple data sources

  2010cites this paper
• The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells.

  2010cites this paper
• Large-Scale Evidence for Conservation of NMD Candidature Across Mammals

  2010cites this paper
• Alternative Splicing and Disease

  2009cites this paper
• ASPECTS EPIGENETIQUES DES CANCERS BRONCHO-PULMONAIRES & IMPLICATION DE L'HISTONE ACETYLTRANSFERASE Tip60

  2009cites this paper
• New insights into alternative splicing using microarray technology

  2009cites this paper
• Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones.

  2009cites this paper
• LSM 1 over-expression in Saccharomyces cerevisiae depletes U 6 snRNA levels

  2009cites this paper
• Nouvelles fonctions de la protéine E2F1 dans le contrôle de l'épissage des transcrits : implication dans la carcinogénèse bronchique

  2009cites this paper
• Therapeutic potential of manipulating VEGF splice isoforms in oncology.

  2009cites this paper
• Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.

  2009cites this paper